| [1] |
Blum HE. Hepatitis B virus: significance of naturally occurring mutants[J]. Intervirology,1993,35(1-4):40-50.
|
| [2] |
Ngui SL, Teo CG. Hepatitis B virus genomic heterogeneity: variation between quasispecies may confound molecular epidemiological analyses of transmission incidents[J]. J Viral Hepat,1997,4(5):309-315.
|
| [3] |
兰林，王宇明，黄燕萍. 慢性乙型肝炎患者病毒准种特性的初步研究[J]. 中华肝脏病杂志,2003,11(4):219-221.
|
| [4] |
董菁，成军，王勤环, 等. 乙型肝炎病毒C基因启动子区准种与变异特点的研究[J]. 中华实验和临床病毒学杂志,2002,16(3):264-266.
|
| [5] |
Domingo E, Sheldon J, Perales C. Viral quasispecies evolution[J]. Microbiol Mol Biol Rev,2012,76(2):159-216.
|
| [6] |
Rodriguez-Frias F, Buti M, Tabernero D, et al. Quasispecies structure, cornerstone of hepatitis B virus infection: Mass sequencing approach[J]. World J Gastroenterol,2013,19(41):6995-7023.
|
| [7] |
Solmone M, Vincenti D, Prosperi M C, et al. Use of massively parallel ultradeep pyrosequencing to characterize the genetic diversity of hepatitis B virus in drug-resistant and drug-naive patients and to detect minor variants in reverse transcriptase and hepatitis B S antigen[J]. J Virol,2009,83(4):1718-1726.
|
| [8] |
Margulies M, Egholm M, Altman WE, et al. Genome sequencing in microfabricated high-density picolitre reactors[J]. Nature,2005,437(7057):376-380.
|
| [9] |
Bentley SD, Parkhill J. Comparative genomic structure of prokaryotes[J]. Annu Rev Genet,2004,38:771-792.
|
| [10] |
Mardis ER. The impact of next-generation sequencing technology on genetics[J]. Trends Genet,2008,24(3):133-141.
|
| [11] |
Merriman B, Rothberg JM. Progress in ion torrent semiconductor chip based sequencing[J]. Electrophoresis,2012,33(23):3397-3417.
|
| [12] |
Gong L, Han Y, Chen L, et al. Comparison of next-generation sequencing and clone-based sequencing in analysis of hepatitis B virus reverse transcriptase quasispecies heterogeneity[J]. J Clin Microbiol,2013,51(12):4087-4094.
|
| [13] |
Rodriguez-Frias F, Buti M, Tabernero D, et al. Quasispecies structure, cornerstone of hepatitis B virus infection: Mass sequencing approach[J]. World J Gastroenterol,2013,19(41):6995-7023.
|
| [14] |
Li KS, Yamashiro T, Sumie A, et al. Hepatitis B virus harboring nucleotide deletions in the core promoter region and genotype B correlate with low viral replication activity in anti-HBe positive carriers[J]. J Clin Virol,2001,23(1-2):97-106.
|
| [15] |
Kohno K, Nishizono A, Terao H, et al. Reduced transcription and progeny virus production of hepatitis B virus containing an 8-bp deletion in basic core promoter[J]. J Med Virol,2000,61(1):15-22.
|
| [16] |
Wu JF, Chang MH. Natural history of chronic hepatitis B virus infection from infancy to adult life - the mechanism of inflammation triggering and long-term impacts[J]. J Biomed Sci,2015,22(4):92-98.
|
| [17] |
Cheng Y, Guindon S, Rodrigo A, et al. Cumulative viral evolutionary changes in chronic hepatitis B virus infection precedes hepatitis B e antigen seroconversion[J]. Gut,2013,62(9):1347-1355.
|
| [18] |
Wang HY, Chien MH, Huang HP, et al. Distinct hepatitis B virus dynamics in the immunotolerant and early immunoclearance phases[J]. J Virol,2010,84(7):3454-3463.
|
| [19] |
Homs M, Buti M, Tabernero D, et al. Quasispecies dynamics in main core epitopes of hepatitis B virus by ultra-deep-pyrosequencing[J]. World J Gastroenterol,2012,18(42):6096-6105.
|
| [20] |
Chen L, Zhang Q, Yu DM, et al. Early changes of hepatitis B virus quasispecies during lamivudine treatment and the correlation with antiviral efficacy[J]. J Hepatol,2009,50(5):895-905.
|
| [21] |
Tong J, Li QL, Huang AL, et al. Complexity and diversity of hepatitis B virus quasispecies: Correlation with long-term entecavir antiviral efficacy[J]. Antiviral Res,2013,99(3):312-317.
|
| [22] |
Liu F, Chen L, Yu DM, et al. Evolutionary patterns of hepatitis B virus quasispecies under different selective pressures: correlation with antiviral efficacy[J]. Gut,2011,60(9):1269-1277.
|
| [23] |
Peveling-Oberhag J, Herrmann E, Kronenberger B, et al. Dynamics of hepatitis B virus quasispecies heterogeneity and virologic response in patients receiving low-to-moderate genetic barrier nucleoside analogs[J]. J Viral Hepat,2013,20(4):234-239.
|
| [24] |
Cheng Y, Guindon S, Rodrigo A, et al. Increased viral quasispecies evolution in HBeAg seroconverter patients treated with oral nucleoside therapy[J]. J Hepatol,2013,58(2):217-224.
|
| [25] |
Nishijima N, Marusawa H, Ueda Y, et al. Dynamics of hepatitis B virus quasispecies in association with nucleos(t)ide analogue treatment determined by ultra-deep sequencing[J]. PLoS One,2012,7(4):e35052.
|
| [26] |
Pallier C, Rodriguez C, Brillet R, et al. Complex dynamics of hepatitis B virus resistance to adefovir[J]. Hepatology,2009,49(1):50-59.
|
| [27] |
Rodriguez C, Chevaliez S, Bensadoun P, et al. Characterization of the dynamics of hepatitis B virus resistance to adefovir by ultra-deep pyrosequencing[J]. Hepatology,2013,58(3):890-901.
|
| [28] |
Solmone M, Giombini E, Vincenti D, et al. Slow response to entecavir treatment in treatment-naive HBV patients is conditioned by immune response rather than by the presence or selection of refractory variants[J]. Antivir Ther,2014,19(2):201-209.
|
| [29] |
Lim SG, Cheng Y, Guindon S, et al. Viral quasi-species evolution during hepatitis Be antigen seroconversion[J]. Gastroenterology, 2007,133(3):951-958.
|
| [30] |
Wu S, Imazeki F, Kurbanov F, et al. Evolution of hepatitis B genotype C viral quasi-species during hepatitis B e antigen seroconversion[J]. J Hepatol,2011,54(1):19-25.
|